Elicio Therapeutics Reports Inducement Grants

About Elicio Therapeutics Brian Piekos Elicio Therapeutics IR@elicio.com to be covered by the safe-harbor provisions of the PSLRA. Such forward-looking statements are based on our expectations and involve risks and uncertainties; consequently, actual results may differ materially from those expressed or implied in the statements due to a number of factors, including, but not limited to, Elicio's plans to research, develop and commercialize its current and future product candidates. Investor Relations Contac ...